APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alectinib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alectinib Industry Growth and Trends Forecast to 2032

23 December 202578 pages

Choose your research edition.

Industry ResearchAlectinib Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Alectinib Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Alectinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alectinib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Alectinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Alectinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alectinib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alectinib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alectinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alectinib include Roche and Everest Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alectinib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alectinib market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alectinib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alectinib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alectinib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alectinib Market by Company

Roche

Everest Pharmaceuticals

Alectinib Segment by Type

150mg*140 Capsules

150mg*26 Capsules

150mg*28 Capsules

20mg*1 Capsule

40mg*1 Capsule

Alectinib Segment by Application

Advanced NSCLC

Recurrent NSCLC

Unresectable NSCLC

Others

Alectinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alectinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alectinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alectinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alectinib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alectinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 150mg*140 Capsules Table 2. Major Company of 150mg*26 Capsules Table 3. Major Company of 150mg*28 Capsules Table 4. Major Company of 20mg*1 Capsule Table 5. Major Company of 40mg*1 Capsule Table 6. Global Alectinib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Alectinib Sales by Type (2021-2026) & (k units) Table 8. Global Alectinib Sales Market Share in Volume by Type (2021-2026) Table 9. Global Alectinib Sales by Type (2021-2026) & (US$ Million) Table 10. Global Alectinib Sales Market Share in Value by Type (2021-2026) Table 11. Global Alectinib Price by Type (2021-2026) & (US$/unit) Table 12. Global Alectinib Sales by Type (2027-2032) & (k units) Table 13. Global Alectinib Sales Market Share in Volume by Type (2027-2032) Table 14. Global Alectinib Sales by Type (2027-2032) & (US$ Million) Table 15. Global Alectinib Sales Market Share in Value by Type (2027-2032) Table 16. Global Alectinib Price by Type (2027-2032) & (US$/unit) Table 17. North America Alectinib Sales by Type (2021-2026) & (k units) Table 18. North America Alectinib Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Alectinib Sales by Type (2021-2026) & (k units) Table 20. Europe Alectinib Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Alectinib Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Alectinib Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Alectinib Sales by Type (2021-2026) & (k units) Table 24. Latin America Alectinib Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Alectinib Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Alectinib Sales by Type (2021-2026) & (US$ Million) Table 27. Alectinib Industry Trends Table 28. Alectinib Industry Drivers Table 29. Alectinib Industry Opportunities and Challenges Table 30. Alectinib Industry Restraints Table 31. Global Alectinib Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Alectinib Revenue Market Share by Company (2021-2026) Table 33. Global Alectinib Sales by Company (2021-2026) & (k units) Table 34. Global Alectinib Sales Share by Company (2021-2026) Table 35. Global Alectinib Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Alectinib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Alectinib Major Company Production Sites and Headquarters Table 38. Global Alectinib Company, Product Type & Application Table 39. Global Alectinib Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Alectinib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Alectinib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Alectinib Sales by Region (2021-2026) & (k units) Table 44. Global Alectinib Sales Market Share in Volume by Region (2021-2026) Table 45. Global Alectinib Sales by Region (2021-2026) & (US$ Million) Table 46. Global Alectinib Sales Market Share in Value by Region (2021-2026) Table 47. Global Alectinib Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Alectinib Sales by Region (2027-2032) & (k units) Table 49. Global Alectinib Sales Market Share in Volume by Region (2027-2032) Table 50. Global Alectinib Sales by Region (2027-2032) & (US$ Million) Table 51. Global Alectinib Sales Market Share in Value by Region (2027-2032) Table 52. Global Alectinib Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Alectinib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Alectinib Sales by Application (2021-2026) & (k units) Table 55. Global Alectinib Sales Market Share in Volume by Application (2021-2026) Table 56. Global Alectinib Sales by Application (2021-2026) & (US$ Million) Table 57. Global Alectinib Sales Market Share in Value by Application (2021-2026) Table 58. Global Alectinib Price by Application (2021-2026) & (US$/unit) Table 59. Global Alectinib Sales by Application (2027-2032) & (k units) Table 60. Global Alectinib Sales Market Share in Volume by Application (2027-2032) Table 61. Global Alectinib Sales by Application (2027-2032) & (US$ Million) Table 62. Global Alectinib Sales Market Share in Value by Application (2027-2032) Table 63. Global Alectinib Price by Application (2027-2032) & (US$/unit) Table 64. North America Alectinib Sales by Application (2021-2026) & (k units) Table 65. North America Alectinib Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Alectinib Sales by Application (2021-2026) & (k units) Table 67. Europe Alectinib Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Alectinib Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Alectinib Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Alectinib Sales by Application (2021-2026) & (k units) Table 71. Latin America Alectinib Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Alectinib Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Alectinib Sales by Application (2021-2026) & (US$ Million) Table 74. Roche Company Information Table 75. Roche Business Overview Table 76. Roche Alectinib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Roche Alectinib Product Portfolio Table 78. Roche Recent Development Table 79. Everest Pharmaceuticals Company Information Table 80. Everest Pharmaceuticals Business Overview Table 81. Everest Pharmaceuticals Alectinib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Everest Pharmaceuticals Alectinib Product Portfolio Table 83. Everest Pharmaceuticals Recent Development Table 84. North America Alectinib Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 85. North America Alectinib Sales by Country (2021-2026) & (k units) Table 86. North America Alectinib Sales Market Share by Country (2021-2026) Table 87. North America Alectinib Sales Forecast by Country (2027-2032) & (k units) Table 88. North America Alectinib Sales Market Share Forecast by Country (2027-2032) Table 89. North America Alectinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 90. North America Alectinib Market Size by Country (2021-2026) & (US$ Million) Table 91. North America Alectinib Market Share by Country (2021-2026) Table 92. North America Alectinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 93. North America Alectinib Market Share Forecast by Country (2027-2032) Table 94. Europe Alectinib Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 95. Europe Alectinib Sales by Country (2021-2026) & (k units) Table 96. Europe Alectinib Sales Market Share by Country (2021-2026) Table 97. Europe Alectinib Sales Forecast by Country (2027-2032) & (k units) Table 98. Europe Alectinib Sales Market Share Forecast by Country (2027-2032) Table 99. Europe Alectinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. Europe Alectinib Market Size by Country (2021-2026) & (US$ Million) Table 101. Europe Alectinib Market Share by Country (2021-2026) Table 102. Europe Alectinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. Europe Alectinib Market Share Forecast by Country (2027-2032) Table 104. Asia-Pacific Alectinib Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 105. Asia-Pacific Alectinib Sales by Country (2021-2026) & (k units) Table 106. Asia-Pacific Alectinib Sales Market Share by Country (2021-2026) Table 107. Asia-Pacific Alectinib Sales Forecast by Country (2027-2032) & (k units) Table 108. Asia-Pacific Alectinib Sales Market Share Forecast by Country (2027-2032) Table 109. Asia-Pacific Alectinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Asia-Pacific Alectinib Market Size by Country (2021-2026) & (US$ Million) Table 111. Asia-Pacific Alectinib Market Share by Country (2021-2026) Table 112. Asia-Pacific Alectinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Asia-Pacific Alectinib Market Share Forecast by Country (2027-2032) Table 114. Latin America Alectinib Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. Latin America Alectinib Sales by Country (2021-2026) & (k units) Table 116. Latin America Alectinib Sales Market Share by Country (2021-2026) Table 117. Latin America Alectinib Sales Forecast by Country (2027-2032) & (k units) Table 118. Latin America Alectinib Sales Market Share Forecast by Country (2027-2032) Table 119. Latin America Alectinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Latin America Alectinib Market Size by Country (2021-2026) & (US$ Million) Table 121. Latin America Alectinib Market Share by Country (2021-2026) Table 122. Latin America Alectinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Latin America Alectinib Market Share Forecast by Country (2027-2032) Table 124. Middle East and Africa Alectinib Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Middle East and Africa Alectinib Sales by Country (2021-2026) & (k units) Table 126. Middle East and Africa Alectinib Sales Market Share by Country (2021-2026) Table 127. Middle East and Africa Alectinib Sales Forecast by Country (2027-2032) & (k units) Table 128. Middle East and Africa Alectinib Sales Market Share Forecast by Country (2027-2032) Table 129. Middle East and Africa Alectinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Middle East and Africa Alectinib Market Size by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Alectinib Market Share by Country (2021-2026) Table 132. Middle East and Africa Alectinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Middle East and Africa Alectinib Market Share Forecast by Country (2027-2032) Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Alectinib Distributors List Table 137. Alectinib Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Alectinib Image Figure 2. Global Alectinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alectinib Market Size (2021-2032) & (US$ Million) Figure 4. Global Alectinib Sales (2021-2032) & (k units) Figure 5. 150mg*140 Capsules Image Figure 6. Global 150mg*140 Capsules Sales YoY Growth (2021-2032) & (k units) Figure 7. 150mg*26 Capsules Image Figure 8. Global 150mg*26 Capsules Sales YoY Growth (2021-2032) & (k units) Figure 9. 150mg*28 Capsules Image Figure 10. Global 150mg*28 Capsules Sales YoY Growth (2021-2032) & (k units) Figure 11. 20mg*1 Capsule Image Figure 12. Global 20mg*1 Capsule Sales YoY Growth (2021-2032) & (k units) Figure 13. 40mg*1 Capsule Image Figure 14. Global 40mg*1 Capsule Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Alectinib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Alectinib Market Share by Type 2025 VS 2032 Figure 17. North America Alectinib Sales Market Share in Volume by Type in 2025 Figure 18. North America Alectinib Sales Market Share in Value by Type in 2025 Figure 19. Europe Alectinib Sales Market Share in Volume by Type in 2025 Figure 20. Europe Alectinib Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Alectinib Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Alectinib Sales Market Share in Value by Type in 2025 Figure 23. Latin America Alectinib Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Alectinib Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Alectinib Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Alectinib Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Alectinib Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Advanced NSCLC Image Figure 30. Global Advanced NSCLC Sales YoY Growth (2021-2032) & (k units) Figure 31. Recurrent NSCLC Image Figure 32. Global Recurrent NSCLC Sales YoY Growth (2021-2032) & (k units) Figure 33. Unresectable NSCLC Image Figure 34. Global Unresectable NSCLC Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Alectinib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Alectinib Market Share by Application 2025 VS 2032 Figure 39. North America Alectinib Sales Market Share in Volume by Application in 2025 Figure 40. North America Alectinib Sales Market Share in Value by Application in 2025 Figure 41. Europe Alectinib Sales Market Share in Volume by Application in 2025 Figure 42. Europe Alectinib Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Alectinib Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Alectinib Sales Market Share in Value by Application in 2025 Figure 45. Latin America Alectinib Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Alectinib Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Alectinib Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Alectinib Sales Market Share in Value by Application in 2025 Figure 49. North America Alectinib Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Alectinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Alectinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Alectinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Alectinib Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Alectinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Alectinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Alectinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Alectinib Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Alectinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Alectinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Alectinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Alectinib Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Alectinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Alectinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Alectinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Alectinib Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Alectinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Alectinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Alectinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Alectinib Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Alectinib Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg*140 Capsules
  • 150mg*26 Capsules
  • 150mg*28 Capsules
  • 20mg*1 Capsule
  • 40mg*1 Capsule
Applications
  • Advanced NSCLC
  • Recurrent NSCLC
  • Unresectable NSCLC
  • Others
Companies covered
  • Roche
  • Everest Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alectinib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alectinib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alectinib Market by Type
  6. 1.3.1 150mg*140 Capsules
  7. 1.3.2 150mg*26 Capsules
  8. 1.3.3 150mg*28 Capsules
  9. 1.3.4 20mg*1 Capsule
  10. 1.3.5 40mg*1 Capsule
  11. 1.4 Global Alectinib Market Size by Type
  12. 1.4.1 Global Alectinib Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Alectinib Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Alectinib Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Alectinib Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Alectinib Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Alectinib Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Alectinib Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Alectinib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alectinib Industry Trends
  2. 2.2 Alectinib Industry Drivers
  3. 2.3 Alectinib Industry Opportunities and Challenges
  4. 2.4 Alectinib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alectinib Revenue (2021-2026)
  2. 3.2 Global Top Players by Alectinib Sales (2021-2026)
  3. 3.3 Global Top Players by Alectinib Price (2021-2026)
  4. 3.4 Global Alectinib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alectinib Major Company Production Sites & Headquarters
  6. 3.6 Global Alectinib Company, Product Type & Application
  7. 3.7 Global Alectinib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alectinib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alectinib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alectinib Tier 1, Tier 2, and Tier 3
4 Alectinib Regional Status and Outlook
  1. 4.1 Global Alectinib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alectinib Historic Market Size by Region
  3. 4.2.1 Global Alectinib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alectinib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alectinib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alectinib Forecasted Market Size by Region
  7. 4.3.1 Global Alectinib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alectinib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alectinib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alectinib by Application
  1. 5.1 Alectinib Market by Application
  2. 5.1.1 Advanced NSCLC
  3. 5.1.2 Recurrent NSCLC
  4. 5.1.3 Unresectable NSCLC
  5. 5.1.4 Others
  6. 5.2 Global Alectinib Market Size by Application
  7. 5.2.1 Global Alectinib Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Alectinib Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Alectinib Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Alectinib Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Alectinib Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Alectinib Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Alectinib Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Alectinib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Alectinib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Alectinib Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Everest Pharmaceuticals
  8. 6.2.1 Everest Pharmaceuticals Company Information
  9. 6.2.2 Everest Pharmaceuticals Business Overview
  10. 6.2.3 Everest Pharmaceuticals Alectinib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Everest Pharmaceuticals Alectinib Product Portfolio
  12. 6.2.5 Everest Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Alectinib Sales by Country
  2. 7.1.1 North America Alectinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alectinib Sales by Country (2021-2026)
  4. 7.1.3 North America Alectinib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alectinib Market Size by Country
  6. 7.2.1 North America Alectinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alectinib Market Size by Country (2021-2026)
  8. 7.2.3 North America Alectinib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alectinib Sales by Country
  2. 8.1.1 Europe Alectinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alectinib Sales by Country (2021-2026)
  4. 8.1.3 Europe Alectinib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alectinib Market Size by Country
  6. 8.2.1 Europe Alectinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alectinib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alectinib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alectinib Sales by Country
  2. 9.1.1 Asia-Pacific Alectinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alectinib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alectinib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alectinib Market Size by Country
  6. 9.2.1 Asia-Pacific Alectinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alectinib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alectinib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alectinib Sales by Country
  2. 10.1.1 South America Alectinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alectinib Sales by Country (2021-2026)
  4. 10.1.3 South America Alectinib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alectinib Market Size by Country
  6. 10.2.1 South America Alectinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alectinib Market Size by Country (2021-2026)
  8. 10.2.3 South America Alectinib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alectinib Sales by Country
  2. 11.1.1 Middle East and Africa Alectinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alectinib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alectinib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alectinib Market Size by Country
  6. 11.2.1 Middle East and Africa Alectinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alectinib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alectinib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alectinib Value Chain Analysis
  2. 12.1.1 Alectinib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alectinib Production Mode & Process
  7. 12.2 Alectinib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alectinib Distributors
  10. 12.2.3 Alectinib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst